ArticleActa neuropathologica communications2018

A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies.

Caterina Giacomini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.